Anthony M Thomas

6866303, Mar 15, 2005

Oct 16, 2002

10/272347

George Szabo - Ortonville MI, US
Anthony Thomas - Detroit MI, US

ITT Manufacturing Enterprises, Inc. - Wilmington DE

F16L037/00

285305, 285921

A fluid quick connector sealingly latches first and second components, one of which has a through bore and the other has a raised bead spaced from a tip end. A retainer is mountable through a transverse bore in one end of the first component and latched to the first component by projections carried on a pair of legs. A flange on the retainer is positioned to engage a surface of the first component to position the retainer on the first component. Inner disposed arms on the retainer engage a constant diameter portion of the second component and resist movement of the raised bead into or out of the bore in the housing when the retainer is in a fully latched position. The flange on the retainer is spaced from the legs of the retainer to enable the legs to be of minimal thickness for a reduced axial length for the retainer.

7014220, Mar 21, 2006

Oct 11, 2004

10/962902

George Szabo - Ortonville MI, US
Anthony Thomas - Detroit MI, US

ITT Manufacturing Enterprises, Inc. - Wilmington DE

F16L 37/00

285305, 285921

A fluid quick connector sealingly latches first and second components, one of which has a through bore and the other has a raised bead spaced from a tip end. A retainer is mountable through a transverse bore in one end of the first component and latched to the first component by projections carried on a pair of legs. A flange on the retainer is positioned to engage a surface of the first component to position the retainer on the first component. Inner disposed arms on the retainer engage a constant diameter portion of the second component and resist movement of the raised bead into or out of the bore in the housing when the retainer is in a fully latched position. The flange on the retainer is spaced from the legs of the retainer to enable the legs to be of minimal thickness for a reduced axial length for the retainer.

20050096327, May 5, 2005

Nov 2, 2004

10/979651

Bradley Caprathe - Livonia MI, US
Shelly Glase - Ann Arbor MI, US
Zissis Konstantinou - Scarborough, CA
Robert Schelkun - Milan MI, US
Susan Sheehan - Dexter MI, US
Anthony Thomas - Ann Arbor MI, US

A61K031/517
C07D043/02

514252170, 514266220, 544284000

This invention relates to compounds of the formula 1 wherein R, R, and Rand Rare defined as in the specification, pharmaceutical compositions containing them and their use in the treatment of central nervous system disorders.

20060157978, Jul 20, 2006

Jan 18, 2006

11/334683

George Szabo - Ortonville MI, US
Anthony Thomas - Detroit MI, US

F16L 37/00

285305000

A fluid quick connector sealingly latches first and second components, one of which has a through bore and the other has a raised bead spaced from a tip end. A retainer is mountable through a transverse bore in one end of the first component and latched to the first component by projections carried on a pair of legs. A flange on the retainer is positioned to engage a surface of the first component to position the retainer on the first component. Inner disposed arms on the retainer engage a constant diameter portion of the second component and resist movement of the raised bead into or out of the bore in the housing when the retainer is in a fully latched position. The flange on the retainer is spaced from the legs of the retainer to enable the legs to be of minimal thickness for a reduced axial length for the retainer.

20090215857, Aug 27, 2009

Aug 29, 2006

12/066740

Thomas Bruno Lanni - Macomb MI, US
Scott Edward Lazerwith - San Francisco CA, US
Susan Mary Kult Sheehan - Gales Ferry CT, US
Anthony Jerome Thomas - Ann Arbor MI, US

Pfizer Products Inc. - Groto CT

A61K 31/40
C07D 207/36

514424, 548541

The present invention provides for compounds of Formula (I),and pharmaceutically acceptable salts thereof, wherein A, J, Z, and Rhave any of the values defined therefore in the specification, and pharmaceutically acceptable salts thereof, that are useful as agents in the treatment of disorders and conditions including attention deficit hyperactivity disorder, neuropathic pain, urinary incontinence, generalized anxiety disorder, depression, schizophrenia, and fibromyalgia. Also provided are pharmaceutical compositions comprising one or more compounds of Formula (I) or pharmaceutically acceptable salts thereof.

55148123, May 7, 1996

Jun 10, 1994

8/257858

Ruth Bucsh - Canton MI
Juan C. Jaen - Plymouth MI
Edgardo Laborde - Lincoln University PA
Anthony J. Thomas - Ann Arbor MI

Warner-Lambert Company - Morris Plains NJ

C07D48708

548452

The instant invention is a selective formation of the Z-oxime and O-alkylation of 1-azabicyclo 2. 2. 1!heptan-3-one and 1-azabicyclo 2. 2. 2!heptan-3-one oximes to produce compounds with muscarinic activity. The process is capable of scale-up for industrial purposes as it provides better yields and ease of preparation. Intermediates are also described.